Marie Jourdan is the Sr Manager, Bioprocess Product Portfolio of Donaldson’s Life Sciences division. She oversees the bioprocess portfolio with the mission to provide innovative solutions for advanced therapies manufacturing, bringing together the company’s acquisitions Univercells Technologies, Purilogics By Donaldson, Isolere Bio By Donaldson, and Solaris Biotech to deliver excellence in bioprocessing.
Marie originally joined Univercells, the parent company, in 2016 where she played a pivotal role in launching the marketing & communication activities, including the successful commercial launch of the NevoLine™ sIPV platform and scale-X™ hydro and carbo bioreactors. In 2020, she was a key driver in the creation of the spin off company Univercells Technologies as VP Marketing & Product Management.
Prior to Univercells, her past assignments include project management at Baxter and research at MedImmune (now AstraZeneca). Marie holds a double master’s degree in Biotechnology Engineering (Polytech, France) and in Business Management (Kedge Business School).